During the meetings, Maze Therapeutics will present additional pharmacokinetic data from its Phase 1 clinical trial of MZE782, as well as preclinical research supporting inhibition of SLC6A19 to slow ...

Psychological Capital and Proactive Coping as Strategic Resources: Extending the Resource-Based View in Informal Micro-Entrepreneurship This article examines how informal micro-entrepreneurs in ...

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and me ...

As financial markets have gained dominance across the globe, especially so in the last four decades, gold has retreated to ...

Listen to the morning keynote session with Reddit's Jess Calef from the 2025 MM+M Media Summit. The pair underscore why the ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

A new study found that walking just a few thousand steps daily can significantly delay Alzheimer’s symptoms.

Q3 2025 Earnings Call November 10, 2025 5:00 PM ESTCompany ParticipantsRick Winningham - CEO & DirectorRhonda Farnum ...

A longstanding push for urgent action on environmental toxins is landing in an unprecedented time in American politics.

Introduction The aetiology of eating disorders (EDs) is complex, involving an interplay of genetic and environmental factors.

The study presents important insights into the regulation of muscle hypertrophy, regulated by Muscle Ankyrin Repeat Proteins (MARPs) and mTOR. The methods are overall solid and complementary, with ...

During the third quarter of 2025 we continued strong execution of our financial strategy, resulting in improved equity, lower leverage and extended cash runway. Our cash runway has now been extended ...